Nantahala Capital Management, LLC Cytokinetics Inc Transaction History

Nantahala Capital Management, LLC

  • $1.68 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024
SELL
$26.88 - $83.49 $1.86 Million - $5.78 Million
-69,240 Reduced 38.63%
110,017 $9.19 Million
Q2 2023

Aug 14, 2023
BUY
$32.62 - $40.75 $4.87 Million - $6.08 Million
149,257 Added 497.52%
179,257 $5.85 Million
Q1 2023

May 15, 2023
BUY
$33.36 - $45.71 $840,605 - $1.15 Million
25,198 Added 524.74%
30,000 $1.06 Million
Q4 2022

Feb 14, 2023
BUY
$35.77 - $51.11 $171,767 - $245,430
4,802 New
4,802 $220,000

Others Institutions Holding CYTK

# of Institutions
409
Shares Held
125M
Call Options Held
4.6M
Put Options Held
2.43M
View Full List

About CYTOKINETICS INC

CYTK Quotes by TradingView
  • Ticker CYTK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 94,144,096
  • Market Cap $4.6B
  • Description
  • Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...
More about CYTK
Track This Portfolio

Track Nantahala Capital Management, LLC Portfolio

Follow Nantahala Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nantahala Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nantahala Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email